1. Home
  2. ORA vs ALKS Comparison

ORA vs ALKS Comparison

Compare ORA & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORA
  • ALKS
  • Stock Information
  • Founded
  • ORA 1965
  • ALKS 1987
  • Country
  • ORA United States
  • ALKS Ireland
  • Employees
  • ORA N/A
  • ALKS N/A
  • Industry
  • ORA Electric Utilities: Central
  • ALKS Biotechnology: Pharmaceutical Preparations
  • Sector
  • ORA Utilities
  • ALKS Health Care
  • Exchange
  • ORA Nasdaq
  • ALKS Nasdaq
  • Market Cap
  • ORA 6.1B
  • ALKS 4.9B
  • IPO Year
  • ORA 2004
  • ALKS 1991
  • Fundamental
  • Price
  • ORA $107.45
  • ALKS $31.51
  • Analyst Decision
  • ORA Strong Buy
  • ALKS Strong Buy
  • Analyst Count
  • ORA 8
  • ALKS 14
  • Target Price
  • ORA $99.13
  • ALKS $41.43
  • AVG Volume (30 Days)
  • ORA 518.0K
  • ALKS 1.8M
  • Earning Date
  • ORA 11-03-2025
  • ALKS 10-23-2025
  • Dividend Yield
  • ORA 0.45%
  • ALKS N/A
  • EPS Growth
  • ORA N/A
  • ALKS 21.99
  • EPS
  • ORA 2.16
  • ALKS 2.08
  • Revenue
  • ORA $906,305,000.00
  • ALKS $1,505,296,000.00
  • Revenue This Year
  • ORA $10.25
  • ALKS N/A
  • Revenue Next Year
  • ORA $14.66
  • ALKS $1.59
  • P/E Ratio
  • ORA $49.66
  • ALKS $15.16
  • Revenue Growth
  • ORA 2.23
  • ALKS N/A
  • 52 Week Low
  • ORA $61.58
  • ALKS $25.17
  • 52 Week High
  • ORA $107.51
  • ALKS $36.45
  • Technical
  • Relative Strength Index (RSI)
  • ORA N/A
  • ALKS 63.86
  • Support Level
  • ORA N/A
  • ALKS $30.70
  • Resistance Level
  • ORA N/A
  • ALKS $31.68
  • Average True Range (ATR)
  • ORA 0.00
  • ALKS 0.77
  • MACD
  • ORA 0.00
  • ALKS 0.32
  • Stochastic Oscillator
  • ORA 0.00
  • ALKS 86.41

About ORA Ormat Technologies Inc.

Ormat Technologies Inc is engaged in the geothermal and recovered energy power business. It is engaged in three business segments: Electricity Segment. where the company develops, builds, owns and operates geothermal, solar PV and recovered energy-based power plants in the United States and geothermal power plants in other countries and sell the electricity generated. Product Segment includes designing, manufacturing and selling equipment for geothermal and recovered energy-based electricity generation and providing services relating to the engineering, procurement and construction of geothermal and recovered energy-based power plants. Energy Storage Segment includes owning and operating grid-connected which provide capacity, energy and ancillary services directly to the electric grid.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: